デフォルト表紙
市場調査レポート
商品コード
1009562

世界の免疫細胞治療市場の分析(2021年):新型コロナウイルス感染症(COVID-19)による成長と変化(2030年まで)

Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change to 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.86円
世界の免疫細胞治療市場の分析(2021年):新型コロナウイルス感染症(COVID-19)による成長と変化(2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の免疫細胞治療市場について調査し、市場の概要、セグメント・地域別の市場規模の推移と予測、新型コロナウイルス感染症(COVID-19)の市場への影響、市場成長の推進要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 新型コロナウイルス感染症(COVID-19)の影響

第5章 市場規模と成長

  • 世界の免疫細胞治療市場(実績値)
    • 市場の推進要因
    • 市場の阻害要因
  • 世界の免疫細胞治療市場(予測値)
    • 市場の推進要因
    • 市場の阻害要因

第6章 免疫細胞治療市場:セグメント別

  • 市場区分:治療法別(実績値・予測値)
    • TIL療法
    • TCR遺伝子治療
    • CAR-T細胞療法
    • ナチュラルキラー細胞療法
  • 市場区分:主要適応症別(実績値・予測値)
    • B細胞悪性腫瘍
    • 前立腺がん
    • 腎細胞がん
    • 肝臓がん
    • 非ホジキンリンパ腫
    • その他
  • 市場区分:用途別(実績値・予測値)
    • 前立腺がん
    • 乳がん
    • 皮膚がん
    • 卵巣がん
    • 脳腫瘍
    • 肺がん
    • その他

第7章 免疫細胞治療市場:地域・国別

  • 市場規模:地域別(実績値・予測値)
  • 市場規模:国別(実績値・予測値)

第8章 アジア太平洋地域の免疫細胞治療市場

  • 市場概要
  • 地域/市場情報・COVID-19の影響・政府イニシアチブ・規制・法人税構造・投資・主要企業など
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第9章 中国の免疫細胞治療市場

  • 市場概要
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第10章 インドの免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第11章 日本の免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第12章 オーストラリアの免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第13章 インドネシアの免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第14章 韓国の免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第15章 西欧の免疫細胞治療市場

  • 市場概要
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第16章 英国の免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第17章 ドイツの免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第18章 フランスの免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第19章 東欧の免疫細胞治療市場

  • 市場概要
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第20章 ロシアの免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第21章 北米の免疫細胞治療市場

  • 市場概要
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第22章 米国の免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第23章 南米の免疫細胞治療市場

  • 市場概要
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第24章 ブラジルの免疫細胞治療市場

  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第25章 中東の免疫細胞治療市場

  • 市場概要
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第26章 アフリカの免疫細胞治療市場

  • 市場概要
  • 市場規模:治療法別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)

第27章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Novartis AG
    • Gilead Sciences Inc. (Kite Pharma)
    • Apac Biotech
    • Dendreon Pharmaceuticals LLC
    • JW CreaGene Co. Ltd

第28章 パイプライン分析

第29章 主な合併・買収

第30章 将来の見通しと潜在性の分析

第31章 付録

目次

Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cellular immunotherapy market.

This report focuses on cellular immunotherapy market which is experiencing strong growth. The report gives a guide to the cellular immunotherapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cellular immunotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cellular Immunotherapy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cellular immunotherapy market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cellular immunotherapy market section of the report gives context. It compares the cellular immunotherapy market with other segments of the cellular immunotherapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cellular immunotherapy indicators comparison.

Scope

Markets Covered: 1) By Therapy: Tumour-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy

2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Others

3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumour; Lung Cancer; Others

Companies Mentioned: Novartis AG; Gilead Sciences Inc. (Kite Pharma); Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cellular Immunotherapy Market Characteristics

3. Cellular Immunotherapy Market Trends And Strategies

4. Impact Of COVID-19 On Cellular Immunotherapy

5. Cellular Immunotherapy Market Size And Growth

  • 5.1. Global Cellular Immunotherapy Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cellular Immunotherapy Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cellular Immunotherapy Market Segmentation

  • 6.1. Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Tumour-Infiltrating Lymphocyte (TIL) Therapy
  • Engineered T Cell Receptor (TCR) Therapy
  • Chimeric Antigen Receptor (CAR)
  • T Cell Therapy
  • Natural Killer (NK) Cell Therapy
  • 6.2. Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • B-cell Malignancies
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Liver Cancer
  • Non-Hodgkin lymphoma
  • Others 3
  • 6.3. Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer
  • Ovarian Cancer
  • Brain Tumour
  • Lung Cancer
  • Others

7. Cellular Immunotherapy Market Regional And Country Analysis

  • 7.1. Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cellular Immunotherapy Market

  • 8.1. Asia-Pacific Cellular Immunotherapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cellular Immunotherapy Market

  • 9.1. China Cellular Immunotherapy Market Overview
  • 9.2. China Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cellular Immunotherapy Market

  • 10.1. India Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cellular Immunotherapy Market

  • 11.1. Japan Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cellular Immunotherapy Market

  • 12.1. Australia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cellular Immunotherapy Market

  • 13.1. Indonesia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cellular Immunotherapy Market

  • 14.1. South Korea Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cellular Immunotherapy Market

  • 15.1. Western Europe Cellular Immunotherapy Market Overview
  • 15.2. Western Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cellular Immunotherapy Market

  • 16.1. UK Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cellular Immunotherapy Market

  • 17.1. Germany Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cellular Immunotherapy Market

  • 18.4. France Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cellular Immunotherapy Market

  • 19.1. Eastern Europe Cellular Immunotherapy Market Overview
  • 19.2. Eastern Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cellular Immunotherapy Market

  • 20.1. Russia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cellular Immunotherapy Market

  • 21.1. North America Cellular Immunotherapy Market Overview
  • 21.2. North America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cellular Immunotherapy Market

  • 22.1. USA Cellular Immunotherapy Market Overview
  • 22.2. USA Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cellular Immunotherapy Market

  • 23.1. South America Cellular Immunotherapy Market Overview
  • 23.2. South America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cellular Immunotherapy Market

  • 24.1. Brazil Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cellular Immunotherapy Market

  • 25.1. Middle East Cellular Immunotherapy Market Overview
  • 25.2. Middle East Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cellular Immunotherapy Market

  • 26.1. Africa Cellular Immunotherapy Market Overview
  • 26.2. Africa Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cellular Immunotherapy Market Competitive Landscape And Company Profiles

  • 27.1. Cellular Immunotherapy Market Competitive Landscape
  • 27.2. Cellular Immunotherapy Market Company Profiles
    • 27.2.1. Novartis AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Gilead Sciences Inc. (Kite Pharma)
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Apac Biotech
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Dendreon Pharmaceuticals LLC
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. JW CreaGene Co. Ltd
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Cellular Immunotherapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Cellular Immunotherapy Market

30. Cellular Immunotherapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer